HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pelemans, H. Articles by Balzarini, J. Search for Related Content PubMed PubMed Citation Articles by Pelemans, H. Articles by Balzarini, J. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 51, 34234-34239, December 18, 1998

Mutational Analysis of Tyr-318 within the Non-nucleoside Reverse Transcriptase Inhibitor Binding Pocket of Human Immunodeficiency Virus Type I Reverse Transcriptase

From the Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

The highly conserved Tyr-318 is part of the non-nucleoside reverse transcriptase inhibitor (NNRTI)-specific lipophilic pocket of human immunodeficiency virus type I reverse transcriptase (RT) and makes contact within 4 Å with the NNRTIs in all reported RT/NNRTI complexes. Using site-directed mutagenesis, six mutant RTs were constructed bearing the mutations Y318H, Y318K, Y318L, Y318C, Y318W, and Y318F. We found that only the Y318W and Y318F mutant RTs retained substantial RT activity, whereas the catalytic activities of the Y318K, Y318C, Y318H, and Y318L RT mutants were less than 5% of the wild-type activity. The Y318F mutant RT retained substantial sensitivity to the majority of NNRTIs tested, whereas the Y318W mutant RT showed varying degrees of resistance to NNRTIs. Subunit-specific site-directed mutagenesis revealed that there was no difference in the catalytic activity or resistance/sensitivity spectrum toward NNRTIs regardless of whether the Tyr-318 mutation was introduced in both subunits or only in the p66 subunit of RT. Recombinant viruses harboring the Y318F or Y318W mutation in the RT showed a similar resistance/sensitivity pattern to NNRTIs as their corresponding 318 mutant recombinant RTs. Our findings stress a functional or structural role for Tyr-318 in wild-type RT and argue for the design of novel NNRTIs that interact more closely with this amino acid in the NNRTI-specific pocket of human immunodeficiency virus type I RT.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. Hachiya, E. N. Kodama, S. G. Sarafianos, M. M. Schuckmann, Y. Sakagami, M. Matsuoka, M. Takiguchi, H. Gatanaga, and S. Oka Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors J. Virol., April 1, 2008; 82(7): 3261 - 3270. [Abstract] [Full Text] [PDF]

				R. Chen, M. Yokoyama, H. Sato, C. Reilly, and L. M. Mansky Human Immunodeficiency Virus Mutagenesis during Antiviral Therapy: Impact of Drug-Resistant Reverse Transcriptase and Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors on Human Immunodeficiency Virus Type 1 Mutation Frequencies J. Virol., September 15, 2005; 79(18): 12045 - 12057. [Abstract] [Full Text] [PDF]

				J. Auwerx, F. Rodriguez-Barrios, F. Ceccherini-Silberstein, A. San-Felix, S. Velazquez, E. De Clercq, M.-J. Camarasa, C.-F. Perno, F. Gago, and J. Balzarini The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A Mol. Pharmacol., September 1, 2005; 68(3): 652 - 659. [Abstract] [Full Text] [PDF]

				F. Ceccherini-Silberstein, F. Gago, M. Santoro, C. Gori, V. Svicher, F. Rodriguez-Barrios, R. d'Arrigo, M. Ciccozzi, A. Bertoli, A. d. Monforte, et al. High Sequence Conservation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase under Drug Pressure despite the Continuous Appearance of Mutations J. Virol., August 15, 2005; 79(16): 10718 - 10729. [Abstract] [Full Text] [PDF]

				J. Balzarini, J. Auwerx, F. Rodriguez-Barrios, A. Chedad, V. Farkas, F. Ceccherini-Silberstein, C. Garcia-Aparicio, S. Velazquez, E. De Clercq, C.-F. Perno, et al. The Amino Acid Asn136 in HIV-1 Reverse Transcriptase (RT) Maintains Efficient Association of Both RT Subunits and Enables the Rational Design of Novel RT Inhibitors Mol. Pharmacol., July 1, 2005; 68(1): 49 - 60. [Abstract] [Full Text] [PDF]

				J. Auwerx, M. Stevens, A. R. Van Rompay, L. E. Bird, J. Ren, E. De Clercq, B. Oberg, D. K. Stammers, A. Karlsson, and J. Balzarini The Phenylmethylthiazolylthiourea Nonnucleoside Reverse Transcriptase (RT) Inhibitor MSK-076 Selects for a Resistance Mutation in the Active Site of Human Immunodeficiency Virus Type 2 RT J. Virol., July 15, 2004; 78(14): 7427 - 7437. [Abstract] [Full Text] [PDF]

				J. Auwerx, R. Esnouf, E. De Clercq, and J. Balzarini Susceptibility of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Type 1 Reverse Transcriptase Chimeras to Non-Nucleoside RT Inhibitors Mol. Pharmacol., January 1, 2004; 65(1): 244 - 251. [Abstract] [Full Text] [PDF]

				P. R. Harrigan, M. Salim, D. K. Stammers, B. Wynhoven, Z. L. Brumme, P. McKenna, B. Larder, and S. D. Kemp A Mutation in the 3' Region of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase (Y318F) Associated with Nonnucleoside Reverse Transcriptase Inhibitor Resistance J. Virol., June 5, 2002; 76(13): 6836 - 6840. [Abstract] [Full Text] [PDF]

				H. Pelemans, R. Esnouf, E. De Clercq, and J. Balzarini Mutational Analysis of Trp-229 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Identifies This Amino Acid Residue as a Prime Target for the Rational Design of New Non-Nucleoside RT Inhibitors Mol. Pharmacol., May 1, 2000; 57(5): 954 - 960. [Abstract] [Full Text]